EQUASENS (ex Pharmagest Interactive): New ticker code


Villers-lès-Nancy, 15 June 2022 – 06:30pm (CET)

PRESS RELEASE

EQUASENS (formally PHARMAGEST INTERACTIVE)

changes its ticker code to become EQS

The Extraordinary General Meeting of the Shareholders held on 6 May at the company’s headquarters adopted the resolution to change the company’s name to EQUASENS.

According to the notice Euronext published on the 03.06.2022, the product name and the symbol of the ordinary shares of PHARMAGEST INTERACTIVE are modified as follows:

Stock Old
product name
New
product name
Old
ticker code
New
ticker code
Effective date
Euronext (Paris)
Compartment A
PHARMAGEST INTERACTIVE  EQUASENS PHA EQS 08.06.2022

No changes concerning Code ISIN and Euronext: FR0012882389

Financial Calendar:

  • Annual General Meeting on 28 June 2022 in Villers-lès-Nancy. Shareholders are invited to regularly consult the section devoted to the General Meeting on its website www.equasens.com – Section Investisseurs / Assemblée Générale for information about the procedures for participating.
  • H1 2022 revenue: 3 August 2022 (after the close of trading).
  • H1 2022 results: 23 September 2022 (after the close of trading).

About Equasens Group:

With more than 1,200 employees fulfilling a vital role as “Citizens in the Service of Health and Well-Being”, Equasens Group is today a key player in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) in both primary and secondary care sectors.

With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens Group is currently developing the leading healthcare platform and a unique ecosystem in France and Europe benefiting people by making available the very best of technology.

Listed on Euronext Paris™ – Compartment A
Indexes: MSCI GLOBAL SMALL CAP – GAÏA Index 2020CAC® SMALL and CAC® All-Tradable

Included under the European Rising Tech label

Eligible for the Deferred Settlement Service (“Service à Réglement Différé” – SRD) and equity savings accounts invested in small and mid caps (PEA-PME)
ISIN : FR0012882389 – Code Mnémonique EQS

For all the latest news on Equasens Group go to www.equasens.com

              

CONTACTS

Analyst and Investor Relations:
Chief Administrative and Financial Officer: Jean-Yves SAMSON
Tél. +33 (0)3 83 15 90 67 – jean-yves.samson@equasens.com

Media Relations:
FIN’EXTENSO – Isabelle APRILE

Tél. +33 (0)1 39 97 61 22 – i.aprile@finextenso.fr

PHARMAGEST INTERACTIVE



Source link

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy